Pepilix Retatrutide 20mg vial
Research Peptide

Retatrutide 20mg

Lyophilised Powder · ≥99% HPLC-Verified Purity
£75.00
In Stock

Retatrutide is studied in research literature as a triple receptor agonist, acting on GIP, GLP-1 and glucagon pathways. Pepilix supplies it as a lyophilised powder, independently verified for purity, and shipped under proper cold-chain conditions — strictly for qualified laboratory research use.

Strength
20mg
Purity
≥99% (HPLC)
Format
Lyophilised Powder
Certificate of Analysis
Included with every order
⚠ For laboratory research use only. Not for human or veterinary use, consumption, or therapeutic application. Must be handled by qualified research professionals in accordance with applicable safety protocols.

Storage Information

Store the lyophilised powder at -20°C for short-term use or -80°C for long-term storage, protected from light. Once reconstituted, store at +2°C to +4°C and use within 20-30 days. Do not refreeze reconstituted solution.

Delivery

UK orders placed before 2PM (Mon–Fri) or 12PM (Sat) are dispatched same-day via tracked next-day delivery. Free delivery on orders over £150; £6.99 for orders under this amount. Local collection is available in York by arrangement. International orders ship via tracked courier, typically 3–7 working days.

Frequently Asked Questions

What is Retatrutide studied for?

Retatrutide is studied in research literature as a triple receptor agonist acting on GIP, GLP-1 and glucagon pathways. Pepilix supplies it strictly as a lyophilised research compound for qualified laboratory use.

Is Retatrutide suitable for human use?

No. All Pepilix products, including Retatrutide, are strictly for laboratory research purposes only and are not approved, intended, or suitable for human or animal consumption, clinical use, or therapeutic applications.

Do you provide a Certificate of Analysis?

Yes. Every Pepilix peptide order includes a Certificate of Analysis documenting peptide identity, purity percentage via HPLC, batch number, and date of manufacture.

You May Also Be Researching